Spirio And Virgo Relationship

Eat Sleep Burn

Best Weight Loss Programs That Work

Get Instant Access

1. Pfister DG, Horwitz RI (1987) The rightward shift of colon cancer. Aging or artifact? J Clin Gastroenterol 9:58-61

2. Nelson RL (1998) Division of the colorectum into anatomic subsites: why and where? J Surg Oncol 69:1-3

3. Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49:33-64

4. Nakaji S, Umeda T, Shimoyama T et al (2003) Environmental factors affect colon carcinoma and rectal carcinoma in men and women differently. Int J Colorectal Dis 18:481-486

5. Gatta G, Capocaccia R, Coleman MP et al (2000) Toward a comparison of survival in American and European cancer patients. Cancer 89:893-900

6. Gatta G, Capocaccia R, Sant M et al (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 47:533-538

7. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156

8. Capocaccia R, Colonna M, Corazziari I et al (2002) Measuring cancer prevalence in Europe: the EURO-PREVAL project. Ann Oncol 13:831-839

9. Micheli A, Mugno E, Krogh V et al (2002) Cancer prevalence in European registry areas. Ann Oncol 13:840-865

10. Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97:72-81

11. Verdecchia A, Micheli A, Colonna M et al (2002) A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol 13:1128-1139

12. Gatta G, Ciccolallo L, Capocaccia R et al (2003) Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 39:2214-2222

13. Levi F, Lucchini F, Negri E et al (2003) Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol 14:490-495

14. Jemal A, Clegg LX, Ward E et al (2004) Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101:3-27

15. Levi F, Lucchini F, Negri E et al (2004) Trends in cancer mortality in the European Union and accession countries, 1980-2000. Ann Oncol 15:1425-1431

16. Parkin DM (2004) International variation. Oncogene 23:6329-6340

17. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108

18. Flood DM, Weiss NS, Cook LS et al (2000) Colorectal cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control 11:403-411

19. Marchand LL (1999) Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans. J Natl Cancer Inst Monogr 26: 101-105

20. Le Marchand L, Kolonel LN (1992) Cancer in Japanese migrants to Hawaii: interaction between genes and environment. Rev Epidemiol Santé Publique 40: 425-430

21. Stemmermann GN, Nomura A, Mower HF et al (1977) Gastrointestinal carcinoma in the Japanese of Hawaii: a status report. Natl Cancer Inst Monogr 47:169-172

22. Bouchardy C, Parkin DM, Khlat M (1994) Cancer mortality among Chinese and South-East Asian migrants in France. Int J Cancer 58:638-643

23. Whittemore AS, Wu-Williams AH, Lee M et al (1990) Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst 82:915-926

24. Parkin DM, Iscovich J (1997) Risk of cancer in migrants and their descendants in Israel: II. Carcinomas and germ-cell tumours. Int J Cancer 70:654-660

25. de Leon ML, Schoetz DJ Jr, Coller JA et al (1987) Colorectal cancer: Lahey Clinic experience, 1972-1976. An analysis of prognostic indicators. Dis Colon Rectum 30:237-242

26. Cady B, Stone MD, Wayne J (1993) Continuing trends in the prevalence of right-sided lesions among col-orectal carcinomas. Arch Surg 128:505-509

27. Slater GI, Haber RH, Aufses AH (1984) Changing distribution of carcinoma of the colon and rectum. Surg Gynecol Obstet 158:216-218

28. Sariego J, Byrd ME, Kerstein M et al (1992) Changing patterns in colorectal carcinoma: a 25-year experience. Am Surg 58:686-691

29. Nazarian HK, Giuliano AE, Hiatt JR (1993) Colorectal carcinoma: analysis of management in two medical eras. J Surg Oncol 52:46-49

30. Cheng X, Chen VW, Steele B et al (2001) Subsite-spe-cific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer 92:2547-2554

31. Lanier AP, Wychulis AR, Dockerty MB et al (1973) Colorectal cancer in Rochester, Minnesota 1940-1969. Cancer 31:606-615

32. Vobecky J, Leduc C, Devroede G (1984) Sex differences in the changing anatomic distribution of colorectal carcinoma. Cancer 54:3065-3069

33. Lynch HT, Smyrk T, Lynch J (1997) An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 93:84-99

34. Ponz de Leon M, Marino M, Benatti P et al (2004) Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol 15:940-946

35. Pisani P, Parkin DM, Bray F et al (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18-29

36. Boffetta P, Parkin DM (1994) Cancer in developing countries. CA Cancer J Clin 44:81-90

37. Scheiden R, Sand J, Weber J et al (2003) Rectal cancer in Luxembourg: a national population-based data report, 1988-1998. BMC Cancer 3:27

38. Quinn MJ, d'Onofrio A, Moller B et al (2003) Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol 14:1148-1152

39. Forman D, Stockton D, Moller H et al (2003) Cancer prevalence in the UK: results from the EUROPREVAL study. Ann Oncol 14:648-654

40. Coleman MP, Gatta G, Verdecchia A et al (2003) EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14[Suppl 5]:v128-149

41. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16:481-488

42. Boyle P, d'Onofrio A, Maisonneuve P et al (2003) Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann Oncol 14:1312-1325

43. Boyle P, Langman JS (2000) ABC of colorectal cancer: epidemiology. BMJ 321:805-808

44. Beral V, Banks E, Reeves G et al (1999) Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat 4:191-210

45. Fernandez E, La Vecchia C, Balducci A et al (2001) Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 84:722-727

46. Ward E (2005) Colorectal cancer facts and figures-special edition 2005. American Cancer Society, available from URL: http://www.cancer.org/downloads/STT/ CAFF2005CR4PWSecured.pdf

47. Sant M, Aareleid T, Berrino F et al (2003) EUROCARE-3: survival of cancer patients diagnosed 1990-94 -results and commentary. Ann Oncol 14[Suppl 5]: v61-118

48. Micheli A, Coebergh JW, Mugno E et al (2003) European health systems and cancer care. Ann Oncol 14[Suppl 5]:v41-60

49. Boyle P (1989) Relative value of incidence and mortality data in cancer research. Recent Results Cancer Res 114:41-63

50. Tomatis L (ed) (1990) Cancer: causes, occurrence and control. IARC Sci Publ No 100. IARC, Lyon

51. Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191-1308

52. Shike M (1999) Diet and lifestyle in the prevention of colorectal cancer: an overview. Am J Med 106:11S-15S

53. Cummings JH, Bingham SA (1998) Diet and the prevention of cancer. BMJ 317:1636-1640

54. Waterhouse J, Muir CS, Shanmugaratnam K, Powell J (1982) Incidence in five continents. IARC Sci Publ 4:42

55. Winawer SJ, Fletcher RH, Miller L et al (1997) Col-orectal cancer screening: clinical guidelines and rationale. Gastroenterology 112:594-642

56. Cheng X, Chen VW, Steele B et al (2001) Subsite-spe-cific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer 92:2547-2554

57. Boyle P, Zaridze DG, Smans M (1985) Descriptive epidemiology of colorectal cancer. Int J Cancer 36:9-18

58. Devesa SS, Chow WH (1993) Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 71:3819-3826

59. Griffin PM, Liff JM, Greenberg RS, Clark WS (1991) Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology 100:1033-1040

60. Arvanitis ML, Jagelman DG, Fazio VW et al (1990) Mortality in patients with familial adenomatous poly-posis. Dis Colon Rectum 33:639-642

61. Vasen HFA (1994) What is hereditary nonpolyposis colorectal cancer (HNPCC). Anticancer Res 14: 1613-1616

62. Boring CC, Squires TS, Health CW et al (1992) Cancer statistics for African Americans. CA Cancer J Clin 42:7-17

63. Nelson RL, Dollear T, Freels S, Persky V (1997) The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 80:193-197

64. Albanes D, Jones DY, Schatzkin A et al (1988) Adult stature and risk of cancer. Cancer Res 48:1658-1662

65. Hill M (1978) Etiology of the adenoma-carcinoma sequence. Major Probl Pathol 10:153-162

66. O'Brien MJ, Winawer SJ, Zauber AG et al (1990) The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98:371-379

67. McKusic VA (1974) Genetics and large bowel cancer. Am J Dig Dis 19:954-957

68. National Cancer Institute (2005) Genetics of Colorectal Cancer (PDQ®). U.S. National Institutes of Health, available from URL: http://www.nci.nih.gov/cancer-topics/pdq/genetics/colorectal/healthprofessional [Accessed 2005 March]

69. Bülow S (1987) Familial polyposis coli. Dan Med Bull 34:1-15

70. Spirio L, Olschwang S, Groden J et al (1993) Alleles of the APC gene: an attenuated form of familial polypo-sis. Cell 75:951-957

71. Oldfield MC (1954) The association of familial polypo-sis of the colon with multiple sebaceous cysts. Br J Surg 41:534-541

72. Turcot J, Depres JP, St Pierre F (1959) Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 2:465-468

73. Lynch HT, Lynch PM (1978) Heredity and gastrointestinal tract cancer. In: Lipkin M, Good RA (eds) Gastrointestinal tract cancer. Plenum Press, New York

74. Lynch HT, Lynch JF (1993) The Lynch syndromes. Curr Opin Oncol 5:687-696

75. Rustgi AK (1994) Hereditary gastrointestinal polypo-sis and non polyposis syndromes. N Engl J Med 331:1694-1702

76. Vasen HF, Mecklin JP, Meera Khan P et al (1991) The international collaborative group on hereditary non-polyposis colorectal cancer. Dis Colon Rectum 34:424-425

77. Jass JR, Williams CB, Bussey HJ (1988) Juvenile poly-posis - a precancerous condition. Histopathology 13:619-630

78. Reid JD (1974) Intestinal carcinoma in the Peutz-Jeghers syndrome. JAMA 229:833-834

79. St John DJ, McDermott FT, Hopper JL et al (1993) Cancer risk in relatives of patients with common colorec-tal cancer. Ann Intern Med 118:785-790

80. Fuchs CS, Giovannucci EL, Colditz GA et al (1994) A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331:1669-1674

81. Negri E, Braga C, La Vecchia C et al (1998) Family history of cancer and risk of colorectal cancer in Italy. Br J Cancer 77: 174-179

82. Johns LE, Houlston RS (2001) A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96:2992-3003

83. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL (1987) Natural history of untreated colonic polyps. Gastroenterology 93:1009-1013

84. Aitken JF, Bain CJ, Ward M et al (1996) Risk of colorectal adenomas in patients with a family history of colorectal cancer: some implications for screening programs. Gut 39:105-108

85. Edwards FC, Truelove SC (1964) The course and prognosis of ulcerative colitis. Gut 5:1-22

86. Lee EC, Truelove SC (1980) Proctocolectomy for ulcer-ative colitis. World J Surg 4:195-201

87. Kewenter J, Ahlman H, Hulten L (1978) Cancer risk in extensive ulcerative colitis. Ann Surg 188:824-828

88. Sandler RS, Sandler DP (1983) Radiation-induced cancers of the colon and rectum: assessing the risk. Gas-troenterology 84:51-57

89. Vernick LJ, Kuller LH (1981) Cholecystectomy and right-sided colon cancer: an epidemiological study. Lancet 2:381-383

90. Bristol JB, Williamson RC (1981) Ureterosigmoidosto-my and colon carcinogenesis. Science 214:351

91. McGregor RA, Bacon HE (1958) Multiple cancers in colon surgery; report of 162 cases. Surgery 44:828-833

92. Weiss NS, Daling JR, Chow WH (1981) Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst 67:57-60

93. Tominaga S, Kuroishi T (1997) An ecological study on diet/nutrition and cancer in Japan. Int J Cancer Suppl 10:2-6

94. Willett WC (2001) Diet and cancer: one view at the start of the millenium. Cancer Epidemiol Biomarkers Prev 10:3-8

95. Chiu BC, Ji BT, Dai Q et al (2003) Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev 12:201-208

96. Haenszel W, Correa P (1971) Cancer of the colon and rectum and adenomatous polyps. A review of epi-demiologic findings. Cancer 28:14-24

97. Stubbs RS (1983) The aetiology of colorectal cancer. Br J Surg 70:313-316

98. Staszewski J, McCall MG, Stenhouse NS (1971) Cancer mortality in 1962-66 among Polish migrants to Australia. Br J Cancer 25:599-610

99. McCullough ML, Robertson AS, Chao A et al (2003) A prospective study of whole grains, fruits, vegetables and colon cancer risk. Cancer Causes Control 14:959-970

100. Hill MJ (1999) Mechanisms of diet and colon carcinogenesis. Eur J Cancer Prev 8 [Suppl 1]:S95-S98

101. Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D (2000) Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev 9:869-873

102. Giovannucci E, Willett WC (1994) Dietary factors and risk of colon cancer. Ann Med 26:443-452

103. Rose DP, Boyar AP, Wynder EL (1986) International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 58:2363-2371

104. Scheppach W, Bingham S, Boutron-Ruault MC et al (1999) WHO consensus statement on the role of nutrition in colorectal cancer. Eur J Cancer Prev 8:57-62

105. La Vecchia C, Negri E, Decarli A (1988) A case-control study of diet and colo-rectal cancer in northern Italy. Int J Cancer 1541:492-498

106. Hu JF, Liu YY, Yu YK et al (1991) Diet and cancer of the colon and rectum: a case-control study in China. Int J Epidemiol 20:362-367

107. Rainey JB, Maeda M, Williams C, Williamson RC (1984) The cocarcinogenic effect of intrarectal deoxy-cholate in rats is reduced by oral metronidazole Br J Cancer 49:631-636

108. Cheah PY (1990) Hypotheses for the etiology of colorectal cancer - an overview. Nutr Cancer 14:5-13

109. McKeown-Eyssen GE, Yeung KS, Bright-See E (1986) Assessment of past diet in epidemiologic studies. Am J Epidemiol 124:94-103

110. Sandhu MS, White IR, McPherson K (2001) Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-ana-lytical approach. Cancer Epidemiol Biomarkers Prev 10:439-446

111. Giovannucci E, Rimm EB, Stampfer MJ et al (1994) Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 54:2390-2397

112. Hsing AW, McLaughlin JK, Chow WH et al (1998) Risk factors for colorectal cancer in a prospective study among U.S. white men. Int J Cancer 77:549-553

113. Cross AJ, Pollock JR, Bingham SA (2002) Red meat and colorectal cancer risk: the effect of dietary iron and haem on endogenous N-nitrosation. IARC Sci Publ 156:205-206

114. Bingham SA, Pignatelli B, Pollock JR et al (1996) Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 17:515-523

115. Thomson B (1999) Heterocyclic amine levels in cooked meat and the implication for New Zealanders. Eur J Cancer Prev 8:201-206

116. Willett WC, Stampfer MJ, Colditz GA et al (1990) Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323:1664-1672

117. Augustsson K, Skog K, Jagerstad M, Dickman PW, Steineck G (1999) Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study Lancet 353:703-707

118. Sinha R, Kulldorff M, Chow WH et al (2001) Dietary intake of heterocyclic amines, meat-derived muta-genic activity, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10:559-562

119. Burkitt DP (1973) Epidemiology of large bowel disease: the role of fibre. Proc Nutr Soc 32:145-149

120. Howe GR, Benito E, Castelleto R et al (1992) Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 84:1887-1896

121. Reddy BS (1999) Role of dietary fiber in colon cancer: an overview. Am J Med 106:16S-19S

122. Alberts DS, Martinez ME, Roe DJ et al (2000) Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 342: 1156-1162

123. Schatzkin A, Lanza E, Corle D et al (2000) Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342:1149-1155

124. Freudenheim JL, Graham S, Horvath PJ (1990) Risks associated with source of fiber and fiber components in cancer of the colon and rectum. Cancer Res 50:3295-3300

125. Newmark HL, Wargovich MJ, Bruce WR (1984) Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst 72:1323-1325

126. Wargovich MJ, Eng VW, Newmark HL et al (1983) Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis 4:1205-1207

127. Martinez ME, Willett WC (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7:163-168

128. Giovannucci E, Stampfer MJ, Colditz GA et al (1998) Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129:517-524

129. Bostick RM, Potter JD, Kushi LH et al (1994) Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5:38-52

130. Ahmed R, Segal I, Hassan H (2000) Fermentation of dietary starch in humans. Am J Gastroenterol 95:1017-1020

131. Caygill CP, Charlett A, Hill MJ (1996) Fat, fish, fish oil and cancer. Br J Cancer 74:159-164

132. Gottlieb MS, Carr JK, Morris DT (1981) Cancer and drinking water in Louisiana: colon and rectum. Int J Epidemiol 10:117-125

133. Morris RD, Audet AM, Angelillo IF et al (1992) Chlori-nation, chlorination by-products, and cancer: a meta-analysis. Am J Public Health 82:955-963

134. Shannon J, White E, Shattuck AL (1996) Relationship of food groups and water intake to colon cancer risk. Cancer Epidemiol Biomarkers Prev 5:495-502

135. Kohlmeier L, Weterings KG, Steck S et al (1997) Tea and cancer prevention: an evaluation of the epidemio-logic literature. Nutr Cancer 27:1-13

136. Rosenberg L, Werler MM, Palmer JR et al (1989) The risks of cancers of the colon and rectum in relation to coffee consumption. Am J Epidemiol 130:895-903

137. Kune G (1996) Causes and control of colorectal cancer. A model for cancer prevention. Kluwer Academic Publishers, Boston

138. Lipkin M, Reddy B, Newmark H (1999) Dietary factors in human colorectal cancer. Annu Rev Nutr 19:545

139. Russo A, Franceschi S, La Vecchia C et al (1998) Body size and colorectal-cancer risk. Int J Cancer 78:161-165

140. Kreger BE, Anderson KM, Schatzkin A et al (1992) Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham Study. Cancer 70:1038-1043

141. Will JC, Galuska DA, Vinicor F et al (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147:816-825

142. Ma J, Pollak MN, Giovannucci E et al (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625

143. Klurfeld M, Weber MM, Kritchevsky D (1987) Inhibition of chemically induced mammary and colon tumor promotion by caloric restriction in rats fed increased dietary fat. Cancer Res 47:2759-2762

144. Reddy S, Wang CX, Maruyama H (1987) Effect of restricted caloric intake on azoxymethane-induced colon tumor incidence in male F344 rats. Cancer Res 47:1226

145. Kune GA, Vitetta L (1992) Alcohol consumption and the etiology of colorectal cancer: a review of the scientific evidence from 1957 to 1991. Nutr Cancer 18:97-111

146. Longnecker MP (1994) Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 5:73-82

147. Newcomb PA, Storer BE, Marcus PM (1993) Cancer of the large bowel in women in relation to alcohol consumption: a case-control study in Wisconsin (United States). Cancer Causes Control S4:405-411

148. Carstensen JM, Bygren LO, Hatschek T (1990) Cancer incidence among Swedish brewery workers. Int J Cancer 45:393-396

149. Slattery ML, Potter JD, Friedman GD et al (1997) Tobacco use and colon cancer. Int J Cancer 70:259-264

150. Knekt P, Hakama M, Järvinen R et al (1998) Smoking and risk of colorectal cancer. Br J Cancer 78:136-139

151. Fredriksson M, Bengtsson NO, Hardell L (1989) Colon cancer, physical activity, and occupational exposures. A case-control study. Cancer 63:1838-1842

152. Harkins L, Volk AL, Samanta M et al (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557-1563

153. Grodstein F, Newcomb PA, Stampfer MJ (1999) Post-menopausal hormone therapy and the risk of colorec-tal cancer: a review and meta-analysis. Am J Med 106:574-582

154. Gerhardsson de Verdier M, London S (1992) Reproductive factors, exogenous female hormones, and col-orectal cancer by subsite. Cancer Causes Control 3:355-360

155. Imperiale TF (2003) Aspirin and the prevention of col-orectal cancer. N Engl J Med 348:879-880

156. National Cancer Institute (2005) Colorectal Cancer (PDQ®): Prevention U.S. National Institutes of Health, available from URL: http://www.nci.nih.gov/cancer-topics/pdq/prevention/colorectal/healthprofessional [Accessed 2005 March]

157. Morrison A (1992) Screening in chronic disease. Oxford University Press, New York

158. Cole P (1978) Basic issues in cancer screening. In: Miller AB (ed) Screening in cancer. International Union Against Cancer, Geneva

159. Eddy D (1980) ACS report on the cancer-related health checkup. CA Cancer J Clin 30:193-240

160. Prorok PC, Chamberlain J, Day NE et al (1984) UICC Workshop on the evaluation of screening programmes for cancer. Int J Cancer 34:1-4

161. Wilson JM, Junger G (1968) Principles and practice of screening for disease. World Health Organization, Geneva

162. Pignone M, Rich M, Teutsch SM et al (2002) Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services

Task Force. Ann Intern Med 137:132-141

163. Mandel JS, Bond JH, Church TR et al (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365-1371

164. Hardcastle JD, Chamberlain JO, Robinson MH et al (1996) Randomised controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 348:1472-1477

165. Kronborg O, Fenger C, Olsen J et al (1996) Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 348:1467-1471

166. Lazovich D, Weiss NS, Stevens NG et al (1995) A case-control study to evaluate efficacy of screening for fecal occult blood. J Med Screen 2:84-89

167. Saito H, Soma Y, Koeda J et al (1995) Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutina-tion test. A case-control study. Int J Cancer 61:465-469

168. Selby JV (1993) Screening sigmoidoscopy for colorectal cancer. Lancet 341:728-729

169. Wahrendorf J, Robra BP, Wiebelt H et al (1993) Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 2:221-227

170. Zappa M, Castiglione G, Grazzini G et al (1997) Effect of fecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer 73:208-210

171. Towler B, Irwig L, Glasziou P et al (1998) A systematic review of the effects of screening for colorectal cancer using the fecal occult blood test, hemoccult. BMJ 317:559-565

172. Mandel JS, Church TR, Bond JH et al (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:1603-1607

173. Imperiale TF, Wagner DR, Lin CY et al (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343:169-174

174. Lieberman DA, Weiss DG, Bond JH et al (2000) Use of colonoscopy to screen asymptomatic adults for col-orectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343:162-168

175. Glick SN, Ralls PW, Balfe DM et al (2000) Screening for colorectal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 215[Suppl]: 231-237

176. Winawer SJ, Stewart ET, Zauber AG et al (2000) A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 342: 1766-1772

177. Muller AD, Sonnenberg A (1995) Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 155:1741-1748

178. Muller AD, Sonnenberg A (1995) Prevention of col-orectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 123:904-910

179. Selby JV, Friedman GD, Quesenberry CP et al (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653-657

180. Segnan N, Senore C, Andreoni B et al (2005) Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 97:347-357

181. Hara AK, Johnson CD, Reed JE et al (1997) Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology 205: 59-65

182. Royster AP, Fenlon HM, Clarke PD et al (1997) CT colonoscopy of colorectal neoplasms: two-dimensional and three-dimensional virtual-reality techniques with colonoscopic correlation. AJR Am J Roentgenol 169:1237-1242

183. Mendelson RM, Foster NM, Edwards JT et al (2000) Virtual colonoscopy compared with conventional colonoscopy: a developing technology. Med J Aust 173:


184. Morra A, Meduri S, Ammar L et al (1999) Colonoscopy with computed tomography with volume reconstruction. The results and a comparison with endoscopy and surgery. Radiol Med 98:162-167

185. Luboldt W, Bauerfeind P, Wildermuth S et al (2000) Colonic masses: detection with MR colonography. Radiology 216:383-388

186. Pescatore P, Glucker T, Delarive J et al (2000) Diagnostic accuracy and interobserver agreement of CT colonography (virtual colonoscopy). Gut 47:126-130

187. Kay CL, Kulling D, Hawes RH et al (2000) Virtual endoscopy - comparison with colonoscopy in the detection of space-occupying lesions of the colon. Endoscopy 32:226-232

188. Spinzi G, Belloni G, Martegani A et al (2001) Computed tomographic colonography and conventional colonoscopy for colon diseases: a prospective, blinded study. Am J Gastroenterol 96:394-400

189. Akerkar GA, Yee J, Hung R et al (2001) Patient experience and preferences toward colon cancer screening: a comparison of virtual colonoscopy and conventional colonoscopy. Gastrointest Endosc 54:310-315

190. Imperiale TF, Ransohoff DF, Itzkowitz SH et al (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351:2704-2714

191. Brown ML, Lipscomb J, Snyder C (2001) The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 22:91-113

192. Brenna A (1999) Manuale di Economia Sanitaria. CISEditore, Milano [Italian]

193. Brown Ml, Hodgson TA, Rice DP (1995) Economic impact of cancer in the United States. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 2nd edn. Oxford University, New York, pp 255-266

194. Brown ML, Fintor L (1995) The economic burden of cancer. In: Greenwald P, Kramer BS, Weed DL (eds) Cancer prevention and control. Marcel-Dekker Publisher, New York, pp 69-81

195. Schrag D, Weeks J (1999) Costs and cost-effectiveness of colorectal cancer prevention and therapy. Semin Oncol 26:561-568

196. Redaelli A, Cranor CW, Okano GJ et al (2003) Screen ing, prevention and socioeconomic costs associated with the treatment of colorectal cancer. Pharmacoeco-nomics 21:1213-1238

197. Selke B, Durand I, Marissal JP (2003) Cost of colorec-tal cancer in France in 1999. Gastroenterol Clin Biol 27:22-27 [French]

198. Brown ML, Riley GF, Schussler N, Etzioni R (2002) Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 40[Suppl 8]: 104-17

199. Crott R (2003) Assessment of cancer cost at the international level: challenges and methodological approaches. Bull Cancer 90:1016-1023

200. Chang S, Long SR, Kutikova L et al (2004) Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol 22:3524-3530

201. Walker AR, Whynes DK, Chamberlain J et al (1991) The hospital costs of diagnostic procedures for col-orectal cancer. J Clin Epidemiol 44:907-914

202. Matasar MJ, Sundararajan V, Grann VR et al (2004) Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy. Drugs Aging 21:113-133

203. Ward S, Kaltenthaler E, Cowan J et al (2003) Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. Health Technol Assess 7:1-93

204. Maroun J, Ng E, Berthelot JM et al (2003) Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can 24:91-101

205. Taplin SH, Barlow W, Urban N et al (1995) Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 87:417-426

206. Fireman BH, Quesenberry CP, Somkin CP et al (1997) Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 18:51-76

207. Dahlberg M, Stenborg A, Pahlman L et al (2002) Cost-effectiveness of preoperative radiotherapy in rectal cancer: results from the Swedish Rectal Cancer Trial. Int J Radiat Oncol Biol Phys 54:654-660

208. Koopmanschap MA, van Roijen L, Bonneux L (1994) Current and future costs of cancer. Eur J Cancer 30A:60-65

209. O'Brien BD, Brown MG, Kephart G (2001) Estimation of hospital costs for colorectal cancer care in Nova Scotia. Can J Gastroenterol 15:43-47

210. Ramsey SD, Mandelson MT, Berry K et al (2003) Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology 125:1645-1650

211. Riley GF, Potosky AL, Lubitz JD et al (1995) Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 33:828-841

212. Penberthy L, Retchin SM, McDonald MK et al (1999) Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer. Health Care Manag Sci 2:149-160

213. Brown ML, Riley GF, Potosky AL et al (1999) Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 37:1249-1259

214. Geddes M, Barchielli A, Carli S et al (1997) Hospital admissions, diagnostic and therapeutic procedures of patients with colorectal cancer during 5 years after diagnosis: population-based study. Epidemiol Prev 21:272-278 [Italian]

215. Seifeldin R, Hantsch JJ (1999) The economic burden associated with colon cancer in the United States. Clin Ther 21:1370-1379

216. Geddes M, Carli S, Ercolanelli M et al (1996) Colorec-tal, lung, and breast cancer care during the three years following the diagnosis: a population-based study. Tumori 82:210-214 [Italian]

217. Virgo KS, Vernava AM, Longo WE et al (1995) Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 273:1837-1841

218. Ross P, Heron J, Cunningham D (1996) Cost of treating advanced colorectal cancer: a retrospective comparison of treatment regimens. Eur J Cancer 32[Suppl 5]: S13-S17

219. Delco F, Egger R, Bauerfeind P et al (2005) Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland. Aliment Pharmacol Ther 21:615-622

220. Loeve F, Brown ML, Boer R et al (2000) Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 92:557-563

221. US Congress Office Technology Assessment (1995) The cost-effectiveness of colorectal cancer screening in average-risk adults. OTA-BP-H-146, US Government Printing Office, Washington DC

222. Helm JF, Russo MW, Biddle AK et al (2000) Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Am J Gas-troenterol 95:3250-3258

223. Berchi C, Bouvier V, Reaud JM et al (2004) Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France. Health Econ 13: 227-238

224. Norum J, Olsen JA (1997) A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer. Ann Oncol 8:1081-1087

225. Whynes DK, Frew EJ, Edwards R et al (2003) Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. Int J Technol Assess Health Care 19:384-395

226. Sonnenberg A (2002) Cost-effectiveness in the prevention of colorectal cancer. Gastroenterol Clin North Am 31:1069-1091

227. Provenzale D (2002) Cost-effectiveness of screening the average-risk population for colorectal cancer. Gas-trointest Endosc Clin N Am 12:93-109

228. Fletcher RH, Colditz GA, Pawlson LG (2002) Screening for colorectal cancer: the business case. Am J Manag Care 8:531-538

229. Frazier AL, Colditz GA, Fuchs CS (2000) Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284:1954-1961

230. Overmoyer B (1999) Breast cancer screening. Med Clin North Am 83:1443-1466

231. Pignone M, Saha S, Hoerger T (2002) Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137:96-104

232. Marshall JR, Fay D, Lance P (1996) Potential costs of flexible sigmoidoscopy-based colorectal cancer screening. Gastroenterology 111:1411-1417

233. Wagner J, Tunis S, Brown M et al (1996) Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young G, Rozen P, Levin B (eds) Prevention and early detection of colorectal cancer. Saunders, London, pp 321-356

234. Vijan S, Hwang EW, Hofer TP et al (2001) Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 111:593-601

235. Sorrentino D, Paduano R, Bernardis V (1999) Colorec-tal cancer screening in Italy: feasibility and cost-effectiveness in a model area. Eur J Gastroenterol Hepatol 11:655-660

236. Khandker RK, Dulski JD, Kilpatrick JB et al (2000) A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 16:799-810

Was this article helpful?

0 0
Supplements For Diabetics

Supplements For Diabetics

All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.

Get My Free Ebook

Post a comment